MGC Pharmaceuticals is preparing to move forward with novel, unique and disruptive research in the medical cannabis sector after securing around €450,000 in flagship...
THE London Stock Exchange’s medical cannabis debutant MGC Pharmaceuticals has released is first quarterly update since listing showing record revenues of almost £500,000.
In the...
LONDON Stock Exchange-listed MGC Pharmaceuticals is to acquire Israeli clinical trial specialist MediCaNL for £3.3m (A$6m) in a share-based transaction.
On completion of the acquisition, MediCaNL...
PERSISTENCE has paid-off for an Israeli businessman and a UK lawyer after the London Stock Exchange issued its first ever listing guidelines for cannabis...
PRESS RELEASE
FRANKFURT-based medical cannabis holding company Bloomwell Group (“Bloomwell,” “Bloomwell Group,” or the “Company”) has closed a significant multi-million Euro funding...